Atossa Therapeutics, Inc. (ATOS)

$1.50 -0.99% $-0.02 Healthcare

Atossa Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of medicines in the areas of oncology and infectious diseases. The company's lead program is Endoxifen, an active metabolite of tamoxifen, which is in Phase II clinical trials to treat and prevent breast cancer. It is also developing AT-H201, an inhalation therapy to improve lung function in severely ill and hospitalized COVID-19 patients; AT-301, a proprietary drug candidate for nasal administration in patients diagnosed with COVID-19; and immunotherapy/chimeric antigen receptor therapy programs for the treatment of breast cancer. It has a research agreement with Dana-Farber Cancer Institute, Inc. to support research of cytokine-coated nanoparticles for the treatment of breast cancer. The company was formerly known as Atossa Genetics Inc. and changed its name to Atossa Therapeutics, Inc. in January 2020. Atossa Therapeutics, Inc. was founded in 2008 and is headquartered in Seattle, Washington.

$189.26M

Dr. Steven C. Quay FCAP, M.D., Ph.D.

6.00

Seattle, WA

Nov 08, 2012

-7.17

$-0.21

13.98

14.35

-143,944.44%

-7.38

0.07

2.38

10,619.48

14.35

-30.18%

-29.18%

Similar stocks (14)

Novavax, Inc.

NVAX

$13.30 -2.28%
Neutral

Ocugen, Inc.

OCGN

$1.17 -3.29%
Neutral

Vaxart, Inc.

VXRT

$0.95 -3.73%
Neutral

Inovio Pharmaceuticals, Inc.

INO

$6.79 -0.29%
Downtrend

Elevation Oncology, Inc.

ELEV

$0.62 2.44%
Downtrend

Ocean Biomedical, Inc.

OCEA

$0.99 -0.02%
Downtrend

GeoVax Labs, Inc.

GOVX

$2.69 -5.28%
Downtrend

iBio, Inc.

IBIO

$1.94 0.26%
Neutral

Jaguar Health, Inc.

JAGX

$1.11 0.91%
Downtrend

Palisade Bio, Inc.

PALI

$3.98 5.11%
Downtrend

Sonnet BioTherapeutics Holdings, Inc.

SONN

$0.87 7.03%
Downtrend

Enveric Biosciences, Inc.

ENVB

$0.50 -0.02%
Downtrend

Tonix Pharmaceuticals Holding Corp.

TNXP

$0.15 -5.93%
Downtrend

CohBar, Inc.

CWBR

$0.43 0.00%
Downtrend

ETF Exposure (21)

iShares Micro-Cap ETF

IWC

0.04637%

$122.48 -0.42%
Uptrend

iShares Russell 2000 Value ETF

IWN

0.0109%

$165.78 0.57%
Uptrend

Vanguard Russell 2000 Index Fund

VTWO

0.01%

$87.90 0.27%
Neutral

Vanguard Russell 2000 Value Index Fund

VTWV

0.01%

$146.11 0.45%
Neutral

iShares Russell 2000 ETF

IWM

0.00674%

$217.37 0.25%
Uptrend

ProShares Ultra Russell2000

UWM

0.002547926542488881%

$41.56 0.56%
Neutral

iShares Russell 2000 Growth ETF

IWO

0.00247%

$277.03 -0.07%
Uptrend

ProShares UltraPro Russell2000

URTY

0.0012561158552205087%

$49.68 0.71%
Neutral

ProShares Hedge Replication ETF

HDG

0.0010644580168107391%

$49.77 0.08%
Uptrend

Vanguard Balanced Index Fund Institutional Shares

VBAIX

0%

$49.45 0.51%
Uptrend

Vanguard Balanced Index Fund Admiral Shares

VBIAX

0%

$49.44 0.51%
Uptrend

Vanguard Balanced Index Fund

VBINX

0%

$49.44 0.51%
Uptrend

Vanguard Extended Market Index Fund Institutional Shares

VIEIX

0%

$134.52 1.86%
Uptrend

Vanguard Institutional Total Stock Market Index Fund Institutional Shares

VITNX

0%

$96.10 0.71%
Uptrend

Vanguard Institutional Total Stock Market Index Fund

VITPX

0%

$96.07 0.71%
Uptrend

Vanguard Total Stock Market Index Fund

VITSX

0%

$134.94 0.72%
Uptrend

Vanguard Russell 3000 Index Fund

VTHR

0%

$248.83 0.06%
Uptrend

Vanguard Total Stock Market Index Fund

VTI

0%

$277.53 0.11%
Uptrend

Vanguard Total Stock Market Index Fund

VTSAX

0%

$134.92 0.72%
Uptrend

Vanguard Russell 2000 Growth Index Fund

VTWG

0%

$202.08 0.07%
Neutral

Vanguard Extended Market Index Fund

VXF

0%

$178.21 0.46%
Uptrend